Sevket On, Vice President and Zone General Manager, Siemens Healthineers Canada commented: “Throughout the term of this partnership, we will provide vendor independent advanced healthcare technology solutions, along with the financial security and technology certainty Canadian hospitals require. This value partnership will allow Hamilton Health Sciences to proactively manage the pressures of growing healthcare costs and increasing patient expectations, while improving clinical outcomes,” he continued.
“We are delighted to enter into a value partnership with Hamilton Health Sciences for the next 15 years,” said David Pacitti, President and Head of the Americas, Siemens Healthineers. “This relationship demonstrates our commitment to working closely with our customers to provide healthcare solutions that help transform care delivery and contribute to better patient experience.”
Hamilton Health Sciences is a community of 15,000 staff, physicians, researchers and volunteers that proudly serves south central Ontario residents, and also provides specialized, advanced care to people from across the province. Hamilton Health Sciences is the only hospital in Ontario that cares for all ages, from pre-birth to end-of-life. Offering world-leading expertise in many areas, including cardiac and stroke care, cancer care, palliative care and pediatrics, Hamilton Health Sciences is also renowned for its healthcare research.
Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion. Further information is available at www.siemens-healthineers.com.
Back to HCB News
